Managing Risks in Health 2.0


By Neil Versel

September 9, 2008 | TORONTO—Interactive media with user-generated content, often generically referred to as Web 2.0, has taken off in health care in the last couple of years. But with all the options and convenience that blogs, wikis, social networking sites, chat rooms, and message boards have opened up for patients and providers alike, the technology known as health 2.0 or medicine 2.0 is not without risk.

“This opens up a multitude of opportunities for patients,” Kevin Clauson, associate professor of pharmacy practice and a specialist in drug information at Nova Southeastern University (Palm Beach Gardens, Fla.), said here Friday at the first Medicine 2.0 Congress, which attracted 180 people from 19 countries for an academic-level discussion on interactive health-IT. He noted that PatientsLikeMe has become a popular forum and virtual support group for those with serious health issues.

Health 2.0 also can open up organizations to embarrassment or possibly even legal liability when it comes to interaction between patients and practitioners. Clauson noted that pharmacists in the U.S. have a “duty to warn” if patients are put in potentially unsafe situations. But it is not clear, Clauson said, if this duty extends to patient-posted content that may indicate that person is taking drugs that may interact with each other.

As more providers move to electronic health records and personal health records that patients can view, the public might be surprised to learn that clinicians have their own form of derogatory slang. Clauson said some popular descriptions he has seen in medical charts include: “CLL” (“chronic low-life”), “LOBNH” (“lights on but nobody home”), and “grave dodger” to describe a chronically ill elderly patient. What happens if patients suddenly start reading such language?

Messages often do get muddled online. E-mails and blogs are wide open to misinterpretation, since it is difficult to communicate tone in typed text. “Poor communication is exacerbated by writing because most people don’t write very well,” Clauson added.

Sometimes, organizations may get hurt by poor judgment that is completely beyond their institutional control. Clauson highlighted a study published in the July issue of the Journal of General Internal Medicine that found that medical students at the University of Florida were less than discrete with some of their Facebook pages. Some belonged to groups called “Physicians Looking for Trophy Wives in Training” or “PIMP: Party of Important Male Physicians.” Others were pictured grabbing the breasts of classmates, visibly drunk, or wearing a lab coat that said “Kevorkian Medical Clinic.”

Clauson recommends that organizations educate their staff about some of the hazards associated with health 2.0 before minor gaffes become major problems. “It is possible to some extent to ameliorate these risks with good judgment and risk management,” he said.

 

 

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

Waters white paper image
Software Helps Doping Control Lab Streamline Results Management
Sponsored by Waters
The Karolinska University Hospital’s Doping Control Lab tests thousands of samples annually for stimulants, diuretics, and other masking agents. Increased regulatory pressure and new technologies increased the number of samples analyzed creating data management challenges. Waters® NuGenesis® Scientific Data Management System and TargetLynx™ Application Manager software were used to reduce the time required to calculate, review and search results.


sas whitepaper92
Managed Innovation, Assured Compliance
Sponsored by SAS
Discovery organizations are identifying a lot of promising compounds, but clinical research processes haven't kept pace with timely testing of all those potential therapies. This white paper describes how SAS® Drug Development supports true innovation across the clinical trial process.

In this white paper you will learn how to:

  • Assemble data to foster better collaboration
  • Get up-to-date information during clinical trials
  • Make informed decisions earlier in the trial process


BlueArc white paper image
Addressing Life Sciences Constantly Growing Data Challenges Research Environments
Sponsored by BlueArc
The continued explosion of raw experimental data, the increased use of video, the growing adoption of new data retention practices, and the move to high throughput computational workflows are all placing new demands on the way life sciences organizations store and manage their data.

Download this white paper to learn about:

  • Factors driving the data explosion in the life sciences
  • New data management issues that must be addressed
  • HPC trends that are placing new demands on storage
  • Storage solution attributes that address performance, manageability, and energy efficiency.


Life Science Webcasts & Podcasts

Medidata Solutions

Rising Clinical Trial Delays and Costs - Addressing the Cause, Not the Symptoms 

medidata podcastProtocol complexity is taking a toll on clinical study speed and efficiency: increasingly complicated and ambitious protocols are not only burdening sites and study volunteers but are also prolonging trials and increasing expenses. In response, sponsors have turned to global study placement, restructured site relationships and new site management practices, but the problem remains.

This podcast will discuss:

  • Why these responses address only the symptoms, not the underlying cause, of rising clinical trial delays and costs.
  • Results of a recent joint Tufts University / Medidata Solutions study.
  • New metrics benchmarking protocol design trends.
  • Systematic protocol design improvements and why they are essential to clinical trial performance excellence.

Speakers: Ken Getz, Senior Research Fellow at the Tufts Center for the Study of Drug Development, and Ed Seguine, General Manager, Trial Planning Solutions at Medidata.

Download Now 



More Podcasts

Job Openings

Director, Center For Information Technology (CIT) - National Institutes of Health  (NIH), Department of Health and Human Service
Located in Bethesda, MD. This position requires:
• High-level vision, leadership, management, and modernization of CIT programs and services.
• Strategic direction and policy development for CIT long-term operations and objectives.
• Serve as a key IT advisor to the NIH Chief Information Officer.
A TOP SECRET security clearance will be required.  More job detail is found at:  http://www.jobs.nih.gov under the Executive Jobs section.Or contact Ms.Winnie Garner at seniorre@od.nih.gov.  Applications must be received ELECTRONICALLY by (11:59 p.m.), December 17, 2008.  DHHS and NIH are Equal Opportunity Employers

Bioinformatics Manager- Lilly Singapore Centre for Drug Discovery
For more information click here 

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.